BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6467944)

  • 1. Studies on some enzymes and sialic acid during progestational contraceptive therapy.
    Chaudhuri C; Mukherjea M
    Contraception; 1984 Jun; 29(6):573-83. PubMed ID: 6467944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Norethisterone enanthate as an injectable contraceptive in puerperal and non-puerperal women.
    Melis GB; Strigini F; Fruzzetti F; Paoletti AM; Rainer E; Düsterberg B; Fioretti P
    Contraception; 1981 Jan; 23(1):77-88. PubMed ID: 6781816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of long-acting progestagen-only injectable contraceptives on carbohydrate metabolism and its hormonal profile.
    Fahmy K; Abdel-Razik M; Shaaraway M; al-Kholy G; Saad S; Wagdi A; al-Azzony M
    Contraception; 1991 Oct; 44(4):419-30. PubMed ID: 1836754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum progesterone and norethisterone levels following injection of norethisterone enanthate in different sites and doses.
    Joshi JV; Hazari KT; Shah RS; Chadha UC; Chitlange S; Gokral JS; Arolkar SG
    Steroids; 1989 Jun; 53(6):751-61. PubMed ID: 2815152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serium protein-bound carbohydrate and seromucoid levels during long-acting progestational contraceptive therapy.
    Saleh FM
    Contraception; 1977 Oct; 16(4):399-407. PubMed ID: 923250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of norethisterone enanthate on endometrial bleeding and changes in coagulation function, ovarian hormones and endometrial histology in Thai women.
    Meng YX; Virutamasen P
    Contraception; 1991 Jul; 44(1):73-82. PubMed ID: 1893702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of medroxyprogesterone acetate contraception on human serum enzymes.
    Mukherjea M; Mukherjee P; Biswas R; Chakraborty AS; Kushari J
    Int J Fertil; 1981; 26(1):35-9. PubMed ID: 6113206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Return to ovulation following the use of long-acting injectable contraceptives: a comparative study.
    Garza-Flores J; Cardenas S; Rodríguez V; Cravioto MC; Diaz-Sanchez V; Perez-Palacios G
    Contraception; 1985 Apr; 31(4):361-6. PubMed ID: 3159544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of injectable norethisterone oenanthate on ovarian hormones in Thai women.
    Werawatgoompa S; Vaivanijkul B; Leepipatpaiboon S; Channiyom K; Virutamasen P; Dusitsin N
    Contraception; 1980 Mar; 21(3):299-309. PubMed ID: 7389353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I clinical trial of two contraceptive preparations. Norethisterone enanthate (NEN) and norethisterone acetate (NET).
    Andino N
    Contraception; 1981 Feb; 23(2):141-55. PubMed ID: 6786825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term use of depot-norethisterone enanthate: effect on blood coagulation factors and menstrual bleeding patterns.
    McEwan JA; Griffin M
    Contraception; 1991 Dec; 44(6):639-48. PubMed ID: 1773620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acceptability of injectable contraceptives in Assiut, Egypt.
    Salem HT; Salah M; Aly MY; Thabet AI; Shaaban MM; Fathalla MF
    Contraception; 1988 Dec; 38(6):697-710. PubMed ID: 2975583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum norethindrone (NET) concentrations following intramuscular NET enanthate injection. Effect upon serum LH, FSH, estradiol and progesterone.
    Goebelsmann U; Stanczyk FZ; Brenner PF; Goebelsmann AE; Gentzschein EK; Mishell DR
    Contraception; 1979 Mar; 19(3):283-313. PubMed ID: 572279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of different doses of norethisterone on ovarian function, serum sex hormone binding globulin and high density lipoprotein-cholesterol.
    Song S; Chen JK; Lu CH; Yang PJ; Yang QY; Fan BC; He ML; Gui YL; Li LM; Fotherby K
    Contraception; 1993 Jun; 47(6):527-37. PubMed ID: 8334889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WHO special programme of research, development and research training in human reproduction. Task force on long-acting agents for the regulation of fertility.
    Contraception; 1982 Jan; 25(1):1-11. PubMed ID: 6460593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood hormone levels in egyptian women on norethisterone oenanthate.
    Saleh FM; Sallam HN; Abdel-Rahman H; Souka AR; El-Sahwi SY; Toppozada HK
    Contraception; 1983 Jul; 28(1):41-51. PubMed ID: 6414760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokeratin 8, 18 and 19 in endometrial epithelium of Norplant and norethisterone enanthate injectable progestogen contraceptive users.
    Wonodirekso S; Hadisaputra W; Affandi B; Siregar B; Rogers PA
    Hum Reprod; 1996 Oct; 11 Suppl 2():144-9. PubMed ID: 8982756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low dose injectable contraceptive norethisterone enanthate 20mg monthly - II. Metabolic side effects.
    Bamji MS; Safaya S; Prema K
    Contraception; 1981 Jan; 23(1):23-36. PubMed ID: 7471743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of norethisterone, estradiol and progesterone after administration of norethisterone oenanthate at different sites: a cross-over study.
    Virutamasen P; Dhanapas S; Leepipatpaiboon S
    Asia Oceania J Obstet Gynaecol; 1987 Mar; 13(1):49-53. PubMed ID: 3593083
    [No Abstract]   [Full Text] [Related]  

  • 20. Alterations in protein, sialic acid and some enzymes in cervical mucus of female rats during NET-EN treatment.
    Bhowmik T; Mukherjea M
    Contraception; 1987 Aug; 36(2):227-37. PubMed ID: 2448083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.